Marios K. Georgakis

Mendelian randomization for studying the effects of perturbing drug targets

Dipender Gill, Marios K. Georgakis, Venexia Walker et al. · Wellcome Open Research · 2021 · 269 citations · Full text

Drug Target, Mendelian Randomization Analyses, Genetics +22

Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms

Nils Kappelmann, Janine Arloth, Marios K. Georgakis et al. · JAMA Psychiatry · 2020 · 268 citations · Full text

Midlife vascular risk factors and risk of incident dementia: Longitudinal cohort and Mendelian randomization analyses in the UK Biobank

Rainer Malik, Marios K. Georgakis, Julia Neitzel et al. · Alzheimer s & Dementia · 2021 · 173 citations · Full text

Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects

Dipender Gill, Marios K. Georgakis, Fotios Koskeridis et al. · Circulation · 2019 · 168 citations · Full text

Targeting the CCL2–CCR2 axis for atheroprotection

Marios K. Georgakis, Jürgen Bernhagen, Laura H. Heitman et al. · European Heart Journal · 2022 · 159 citations · Full text

Vascular Disease, Immunology, Ccl2–ccr2 Axis +16